Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser

The "dermoscopic score of pigmentary and vascular elements" displayed significant change and confirmed the improvement.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied 31 patients with facial melasma treated with five sessions of low-fluence 1064-nm Q-switched Nd:YAG laser at two-week intervals. They report that melasma scores, colorimetric indices and dermoscopic scores improved after treatment, with tolerable side effects. The authors conclude that dermoscopy was superior to the other assessments for diagnosis and follow-up.

Participants
31
Who or what was studied
31 patients with facial melasma
Wavelengths
1064 nm
Limits stated in the abstract
The abstract does not describe a control group or the length of follow-up beyond the single post-treatment assessment at 10 weeks.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Fluence, Melanin. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Devices & Dosimetry

Fractional non ablative 675 nm diode laser versus low fluence high frequency Q- switched 1064 nm nd: YAG laser in the treatment of melasma: a comparative split face trial

Adverse events were mild and transient. Fractional non-ablative 675 nm diode laser is more effective and equally safe compared to Q-switched 1064 nm Nd:YAG laser in treating facial melasma, offering a promising modality for patients with recalcitrant hyperpigmentation.

Trial · October 15, 2025 · Bassiony HM et al.